Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor. - Trial NCT06310980
Access comprehensive clinical trial information for NCT06310980 through Pure Global AI's free database. This phase not specified trial is sponsored by Giulio Frontino and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 34 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Giulio Frontino
IRCCS San Raffaele
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2025
Primary Outcome
Time in range
Summary
The Aim of this interventional study in to assess the effect of the use of a smartpen
 connected by an APP to continuous glucose sensors in a cohort of diabetic adolescents in not
 good metabolic control.
 
 Primary endpoint: time in range Secondary endpoints: other glucometrics, Hba1c, treatment
 satisfaction.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06310980
Device Trial